Supporting this, knockdown of MAGE-A3/A6 or TRIM28 in tumour cells increased the expression of AMPK-α1 and triggered changes in metabolism and signalling that would be expected downstream of AMPK, including inhibition of mTORC1. This evidence concerns the gene MAGEA3 and neoplasm.